Upcoming Medical Conferences in RhodesSearch Criteria : Greece Rhodes
Tissue Engineering and Regenerative Medicine International Society European (TERMIS-EU) Chapter Meeting 2019
May 27 - 31, 2019 | EUR €850 | Rhodes, South Aegean
Tissue Engineering and Regenerative Medicine International Society European (TERMIS-EU) Chapter Meeting is organized by Tissue Engineering and Regenerative Medicine International Society and will be held from May 27 - 31, 2019 at Rhodes, South Aegean, Greece. The Theme of this Conference is Tissue Engineering Therapies: From Concept to Clinical Translation & Commercialization. TERMIS is the most prominent organisation in the field of tissue engineering and regenerative medicine globally. TERMIS promotes education, research, innovation, clinical translation and social responsibility within the field of tissue engineering and regenerative medicine through regular meetings, training courses, scientific and lay publications, outreach activities and other forms of communication. TERMIS also provides an international forum for the informed discussion of challenges and achievements of tissue engineering therapies. The meeting is highly important to scientists, clinicians and industries interested in tissue engineering and regenerative medicine therapies that aspire to revolutionise healthcare with their reparative capacity. Additional details will be posted as soon as they are available.
May 28 - Jun 02, 2019 | Rhodes, South Aegean
4th International Conference on ImmunoMetabolism: Molecular and Cellular Immunology of Metabolism is organized by Aegean Conferences and will be held from May 28 - Jun 02, 2019 at Sheraton Rhodes Resort, Rhodes, South Aegean, Greece. Obesity and its co-morbidities, including atherosclerosis, insulin resistance and diabetes, are a world-wide epidemic. Inflammation in metabolic tissues has emerged as a universal feature of these chronic metabolic disorders. While initial work highlighted the contribution of macrophages to tissue inflammation and insulin resistance, recent studies demonstrate that adaptive and other innate immune cells also participate in obesity-induced pathogenesis of these conditions. However, the molecular and cellular pathways by which the immune system controls tissue and systemic metabolism remain poorly understood. Furthermore, given the different spheres of science that immunologists and experts in metabolism travel in, there has been limited cross-talk between these two communities, which is needed to accelerate future discoveries in this emerging field. Thus, the goal of launching this new Aegean Conference, which we have coined ImmunoMetabolism, is to get these two communities to meet in a conference devoted solely to this topic, thereby fostering a deeper connection and fruitful collaborations amongst the experts in these disparate fields. The meeting will bring together investigators who are at the forefront of immunology or metabolism, and provide opportunities for junior scientists to present posters and discuss ideas with leaders in the developing field of Immunometabolism. Additional details will be posted as soon as they are available.
Jun 02 - 07, 2019 | Rhodes, South Aegean
3rd International Conference on Cytokine Signaling in Cancer is organized by Aegean Conferences and will be held from Jun 02 - 07, 2019 at Sheraton Rhodes Resort, Rhodes, South Aegean, Greece. The milieu of cytokines enables individual cells to shape and modify their collective behavior within tissues and the entire organism. Accordingly, alterations in abundance and physiological responses to these cytokines plays a key role in development and progression of cancers, the diseases where this collective behavior rules go awry. Cytokines promote or counteract malignant transformation of cells and growth of cancer cells through the cell autonomous effects on cell proliferation, survival and motility. Furthermore, effects of cytokines on benign cells shapes the support of or defenses against growing tumor through affecting inflammation, angiogenesis, stromagenesis and anti-tumor immunity. Type of cytokines and physiologic and pathologic context of their action defines the critical importance of these mediators as either pro-tumorigenic or anti-tumorigenic effectors. Accordingly, understanding of alterations of cytokine signaling in cancers is paramount for gaining the insight on the mechanisms of tumor development and progression. Moreover, work in this field is instrumental for understanding the role of cytokines in resistance of human cancers against modern modes of treatment and for devising novel therapeutic approaches that include delivery of anti-tumorigenic cytokines and inactivation of pro-tumorigenic cytokines. Finally, critically important role of cytokines in anti-tumor immunity and immune therapies of cancer further highlights the importance of research on the cytokine signaling in cancer. Rapidly growing knowledge on the cytokine signaling in cancer requires extensive, robust and systematic analysis and synthesis that are hindered by inadequately met need for scientific exchange in this area. The proposed Aegean conference on the cytokine signaling in cancer should fill this gap and bring together outstanding experts in the area and enable exchange the information and ideas important for improving our understanding of cancer etiology, pathogenesis, and responses to therapies as well as devising novel diagnostic approaches and treatment modalities. Additional details will be posted as soon as they are available.
Jun 07 - 12, 2019 | Rhodes, South Aegean
16th International Conference on Innate Immunity is organized by Aegean Conferences and will be held from Jun 07 - 12, 2019 at Sheraton Rhodes Resort, Rhodes, South Aegean, Greece. The purpose of the 16th Innate Immunity is to bring together scientists from all over the world to discuss their latest findings on the various aspects of Innate Immunity. The specific topics include: Evolution of the innate immune system, Host-microbe interactions, Interactions with adaptive immunity, Pathophysiology-Inflammation, Structural biology, and Therapeutic applications. Abstracts are invited from the international community for all these topics. The scientific sessions will convene in the mornings and early afternoons and will include lectures by invited speakers, as well as talks and poster presentations selected from submitted abstracts. The conference has limited participation and a scientific and social program that will maximize scientific interchange. In order to encourage the participation of young scientists, the Aegean Conferences is offering Trainee Travel Awards to offset a portion of the travel expenses to the Conference. The Conference Organizing Committee will select the Award recipients based on the scientific merit of abstracts submitted by applicants. Additional details will be posted as soon as they are available.
Jun 12 - 17, 2019 | Rhodes, South Aegean
12th International Conference on Complement Therapeutics is organized by Aegean Conferences and will be held from Jun 12 - 17, 2019 at Sheraton Rhodes Resort, Rhodes, South Aegean, Greece. The field of complement-targeted drug discovery has experienced an profound transformation during the past decade. With the first complement-specific drugs on the market, clinical experience is gained and novel indications are being explored. At the same time, efforts in both academic and pharmaceutical research have produced new innovative therapeutic concept that interfere at different levels of the complement cascade; many of these candidates are currently undergoing clinical evaluation. Finally, genetic and molecular studies continue to reveal contributions of complement in both orphan and highly prevalent diseases. Apart from offering new hope for patients suffering from such diseases, the study of complement pathways, mutations, and deficiencies also teaches us important lessons about the role of complement in health and disease and allows us to refine our models and tools for applied and basic research. This conference aims to bring together academic and industry scientists and clinical development experts who are focused on contemporary and emerging aspects of complement-mediated disease pathogenesis and the development of therapeutics that modulate this system in a beneficial manner. Topics discussed during the conference include: Molecular mechanisms and targets in complement-related diseases; Novel inhibitors & pipeline compounds; Hematological disorders; Organ & cell transplantation, I/R injury and chronic rejection; Kidney diseases; Neurological & ocular diseases; Acute and chronic inflammatory disorders; Infectious diseases & sepsis; Cancer; Informative complement biomarkers in therapeutic development; Novel and unexpected indications. Additional details will be posted as soon as they are available.